Next Article in Journal
Hyaluronic Acid as an Adjunct to Coronally Advanced Flap Procedures for Gingival Recessions: A Systematic Review and Meta—Analysis of Randomized Clinical Trials
Next Article in Special Issue
The Impact of the COVID-19 Pandemic on Mental Health and Quality of Life in COVID-19 Department Healthcare Workers in Central Greece
Previous Article in Journal
Adequacy of Disease Control by Supraomohyoid Neck Dissection in cT1/T2 Tongue Cancer
Previous Article in Special Issue
Impact of Early Limitation of Therapeutic Effort in Elderly COVID-19 Patients Admitted to the Intensive Care Unit—A Cohort Study
 
 
Review
Peer-Review Record

Neuromuscular Blockade in the Pre- and COVID-19 ARDS Patients

J. Pers. Med. 2022, 12(9), 1538; https://doi.org/10.3390/jpm12091538
by Vasiliki Tsolaki 1,*, George E. Zakynthinos 1,2, Maria-Eirini Papadonta 1, Fotini Bardaka 1, George Fotakopoulos 3, Ioannis Pantazopoulos 4, Demosthenes Makris 1 and Epaminondas Zakynthinos 1
Reviewer 1: Anonymous
Reviewer 2:
J. Pers. Med. 2022, 12(9), 1538; https://doi.org/10.3390/jpm12091538
Submission received: 15 August 2022 / Revised: 3 September 2022 / Accepted: 15 September 2022 / Published: 19 September 2022
(This article belongs to the Special Issue Personalized Medicine in the ICU)

Round 1

Reviewer 1 Report

The manuscript does excellent job demonstrating NMBAs use in the pre- and  Covid-19 Ards patients. A few typo must be fixed.

Author Response

Comment 1: The manuscript does excellent job demonstrating NMBAs use in the pre- and Covid-19 ARDS patients.

Reply 1: We want to thank the reviewer for the valuable suggestion and encouraging comments.

C1: A few typo must be fixed.

R1: Done as recommended.

Author Response File: Author Response.doc

Reviewer 2 Report

Very good summary of pre-COVID and COVID-associated findings. If possible, suggest conducting a meta-analysis of the trials from these two periods. Understandably, there will be more case series and non-randomized reports.

Author Response

Comment:  Very good summary of pre-COVID and COVID-associated findings. If possible, suggest conducting a meta-analysis of the trials from these two periods. Understandably, there will be more case series and non-randomized reports.

 

Reply : We want to thank the reviewer for the valuable suggestion and encouraging comments. According to your recommendations we reviewed the literature and have added 10 more references concerning the incidence of neuromuscular blocker use in Covid-19 ARDS patients (Ref 65-74). Of these only Ref 73 and Ref 74 report on the duration of NMBA use. Please find the revised data in lines 348-360 and lines 397-403.

Author Response File: Author Response.doc

Back to TopTop